Treatment of Felty's syndrome with low-dose oral methotrexate.
Publication/Presentation Date
7-1-1986
Abstract
Recent studies of methotrexate in the treatment of patients with rheumatoid arthritis have precluded patients with neutropenia. We present a patient with rheumatoid arthritis complicated by severe neutropenia and recurrent infections, who was treated with low-dose methotrexate, orally, for 30 months. The patient experienced symptomatic improvement and a significant increase in granulocyte count, and the dosage of steroids was reduced. Low-dose oral methotrexate may be a therapeutic option in select patients with Felty's syndrome.
Volume
29
Issue
7
First Page
902
Last Page
905
ISSN
0004-3591
Published In/Presented At
Allen, L. S., & Groff, G. (1986). Treatment of Felty's syndrome with low-dose oral methotrexate. Arthritis and rheumatism, 29(7), 902–905. https://doi.org/10.1002/art.1780290713
Disciplines
Medicine and Health Sciences
PubMedID
3741502
Department(s)
Department of Medicine
Document Type
Article